Altos Labs
altoslabs.comOperator of a biotechnology company intended to restore cell health and resilience with the goal of reversing disease, injury, and disabilities.
LBX PPS
1Y return
$15.01
Implied Valuation
$5.2B
-40.0% premium
Last Round
Feb 2024
$25.02
PE Growth/Expansion · $8.8B
Activity
0.8
#128 most active
Price per share
12M · USD
Loading chart...
Funding history
$M raised · $B post-money
Loading chart...